Philippe Laffont’s Pediatrix Medical MD Stock Holding History

Philippe Laffont’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,006	Closed	-$250K	–	298
2019 Q4	$250K	Buy	+9,006	New	+$226K	﹤0.01%	337

Other funds holding MD

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Philippe Laffont's MD Position: Q1 2020 in Review

Philippe Laffont sold out of Pediatrix Medical (MD) in Q1 2020, closing a stake of 9,006 shares — an estimated $250K sold.

Philippe Laffont first reported a position in MD in Q4 2019 and held it in 1 quarter. The position peaked at $250K in Q4 2019. 221 funds tracked by Wall St. Rank hold MD as of Q1 2020.

Philippe Laffont reported no remaining Pediatrix Medical position as of Q1 2020 after selling out during the quarter.
Philippe Laffont sold 9,006 Pediatrix Medical shares in Q1 2020, an estimated $250K.
Philippe Laffont first reported a position in Pediatrix Medical in Q4 2019 and held it in 1 quarter.
Philippe Laffont's Pediatrix Medical position peaked at $250K in Q4 2019.
221 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2020.

Based on Coatue Management's 13F filing for Q1 2020, filed 15 May 2020.